The India-Madagascar pharmaceutical trade corridor has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Madagascar were valued at $49.41 million, marking a substantial increase from previous years. This growth is attributed to India's expanding pharmaceutical manufacturing capabilities and Madagascar's increasing demand for quality medicines. The trade relationship has been further bolstered by strategic partnerships and a shared commitment to improving healthcare access in the region.
Key milestones include the establishment of direct shipping routes and the facilitation of regulatory processes, which have streamlined the export of pharmaceutical products. Additionally, India's adherence to international quality standards, such as WHO-GMP, has enhanced the credibility of its pharmaceutical exports, making them more attractive to Malagasy importers. The growth trajectory indicates a promising future for bilateral pharmaceutical trade, with potential for further expansion in both volume and value.
